☆ 4.5 Review

Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis

HEPATOLOGY COMMUNICATIONS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Gastroenterology & Hepatology

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

Zobair M. Younossi et al.

Summary: A comprehensive meta-analysis was conducted to assess the global and regional prevalence, incidence, and mortality of non-alcoholic fatty liver disease (NAFLD). The results showed that the global prevalence of NAFLD is 30% and increasing, highlighting the need for urgent and comprehensive strategies to raise awareness and address NAFLD on local, regional, and global levels.

HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population

Eduardo Vilar-Gomez et al.

Summary: The findings of this study highlight the importance of liver health as a predictor of overall mortality at a population level.

HEPATOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial

Xueyun Wei et al.

Summary: A 12-month randomized clinical trial comparing time-restricted eating (TRE) and daily calorie restriction (DCR) among patients with obesity and nonalcoholic fatty liver disease (NAFLD) found that TRE did not provide additional benefits for reducing intrahepatic triglyceride (IHTG) content, body fat, and metabolic risk factors compared with DCR. These findings support the importance of caloric intake restriction in the management of NAFLD.

JAMA NETWORK OPEN (2023)

添加到收藏夹

Article Cell Biology

Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial

Mark Ezpeleta et al.

Summary: This study compared the effects of alternate day fasting (ADF) combined with exercise to fasting alone, or exercise alone, on intrahepatic triglyceride (IHTG) content in patients with non-alcoholic fatty liver disease (NAFLD). The results showed that combining intermittent fasting with exercise is effective for reducing hepatic steatosis in patients with NAFLD but may offer no additional benefit versus fasting alone.

CELL METABOLISM (2023)

添加到收藏夹

Article Social Sciences, Interdisciplinary

PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis

Neal R. Haddaway et al.

Summary: We have developed a user-friendly tool for producing PRISMA 2020-compliant flow diagrams for users with coding experience and, importantly, for users without prior experience in coding by making use of Shiny. This free-to-use tool will make it easier to produce clear and PRISMA 2020-compliant systematic review flow diagrams. Significantly, users can also produce interactive flow diagrams for the first time, allowing readers of their reviews to smoothly and swiftly explore and navigate to further details of the methods and results of a review.

CAMPBELL SYSTEMATIC REVIEWS (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Effect of 5:2 Fasting Diet on Liver Fat Content in Patients with Type 2 Diabetic with Nonalcoholic Fatty Liver Disease

Yanxin Xiao et al.

Summary: This study found that a 5:2 fasting diet and liraglutide achieved comparable effects in reducing liver fat content in patients with T2DM with NAFLD. Both treatment strategies were safe and effective for glucose control.

METABOLIC SYNDROME AND RELATED DISORDERS (2022)

添加到收藏夹

Article Nutrition & Dietetics

Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial

Hamed Kord Varkaneh et al.

Summary: This study investigates the effects of the 5:2 intermittent fasting diet on patients with non-alcoholic fatty liver disease (NAFLD). The results demonstrate that adhering to the 5:2 intermittent fasting diet can improve anthropometric indices, hepatic steatosis, liver enzymes, triglycerides, and inflammatory biomarkers in NAFLD patients.

FRONTIERS IN NUTRITION (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients

Hanaa Badran et al.

Summary: Intermittent fasting, such as Ramadan fasting (RF), has significant short-term effects on the biochemical, radiological, and anthropometric parameters of non-alcoholic fatty liver disease (NAFLD) patients, especially in early stages and prediabetic individuals.

CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)

添加到收藏夹

Review Nutrition & Dietetics

Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

Cong Yin et al.

Summary: Intermittent fasting has been found to be beneficial for weight management and liver enzyme improvement in patients with NAFLD, showing significant differences in weight, BMI, ALT, and AST compared to the control group. However, there were no significant differences in other metabolic parameters such as TG and TC between the two groups. Further studies are needed to assess the long-term feasibility and safety of intermittent fasting.

FRONTIERS IN NUTRITION (2021)

添加到收藏夹

Review Nutrition & Dietetics

Cardiometabolic Benefits of Intermittent Fasting

Krista A. Varady et al.

Summary: Intermittent fasting can reduce blood pressure, insulin resistance, and oxidative stress, benefiting cardiometabolic health. However, its effects on LDL cholesterol and triglycerides vary. Other health benefits include improved appetite regulation and changes in gut microbiome diversity, but evidence is limited.

ANNUAL REVIEW OF NUTRITION, VOL 41, 2021 (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Metabolic Impact of Intermittent Fasting in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Interventional Studies

Emily Borgundvaag et al.

Summary: Studies evaluating intermittent fasting (IF) in patients with type 2 diabetes mellitus (T2DM) suggest that IF leads to greater weight loss compared to standard diet, while showing similar impact on glycemic control.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

添加到收藏夹

Review Geriatrics & Gerontology

Intermittent fasting: from calories to time restriction

Eleonora Duregon et al.

Summary: Calorie restriction (CR) is a dietary manipulation that can increase health and longevity, and recently, the length and periodicity of daily fasting have emerged as potential drivers behind beneficial health effects. Numerous strategies and eating patterns have been successfully developed to recapitulate the benefits of CR.

GEROSCIENCE (2021)

添加到收藏夹

Review Medicine, General & Internal

Intermittent Fasting and Obesity-Related Health Outcomes An Umbrella Review of Meta-analyses of Randomized Clinical Trials

Chanthawat Patikorn et al.

Summary: This study reviewed the evidence from multiple meta-analyses of randomized clinical trials on the associations of intermittent fasting with obesity-related health outcomes. The findings showed beneficial effects of intermittent fasting on anthropometric and cardiometabolic outcomes, supported by moderate to high quality evidence.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Review Nutrition & Dietetics

Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials

Maria Morales-Suarez-Varela et al.

Summary: Intermittent fasting has beneficial effects on lipid profile, weight loss, and glycemic control for obese and diabetic patients. Limited data suggests it may be a safe intervention for patients with multiple sclerosis, but more research on long-term effects is needed.

NUTRIENTS (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial

Magnus Holmer et al.

Summary: For individuals with obesity and fatty liver, weight loss through diet can effectively improve liver conditions. This study demonstrates that both low-carb high-fat and the 5:2 diet are effective in treating fatty liver caused by obesity.

JHEP REPORTS (2021)

添加到收藏夹

Article Nutrition & Dietetics

Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease

Sara Ebrahimi et al.

INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH (2020)

添加到收藏夹

Review Endocrinology & Metabolism

Intermittent fasting as a nutrition approach against obesity and metabolic disease

Shengjie Zhu et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2020)

添加到收藏夹

Review Nutrition & Dietetics

Effectiveness of Intermittent Fasting and Time-Restricted Feeding Compared to Continuous Energy Restriction for Weight Loss

Corey A. Rynders et al.

NUTRIENTS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease

Muhammad Izzad Johari et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial

Hua Cai et al.

BMC GASTROENTEROLOGY (2019)

添加到收藏夹

Review Medicine, General & Internal

Effects of Intermittent Fasting on Health, Aging, and Disease

Rafael de Cabo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Nutrition & Dietetics

The Effects of Ramadan Fasting on Body Composition, Blood Pressure, Glucose Metabolism, and Markers of Inflammation in NAFLD Patients: An Observational Trial

Fereshteh Aliasghari et al.

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2017)

添加到收藏夹

Article Medicine, General & Internal

Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults A Randomized Clinical Trial

John F. Trepanowski et al.

JAMA INTERNAL MEDICINE (2017)

添加到收藏夹

Review Physiology

Understanding the Physiology of FGF21

Ffolliott Martin Fisher et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)

添加到收藏夹

Review Cell Biology

Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan

Valter D. Longo et al.

CELL METABOLISM (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Eduardo Vilar-Gomez et al.

GASTROENTEROLOGY (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

Exercise and the Liver: Implications for Therapy in Fatty Liver Disorders

Nathan A. Johnson et al.

SEMINARS IN LIVER DISEASE (2012)

添加到收藏夹

Article Medicine, General & Internal

Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates.

Frank M. Sacks et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

The future of obesity: new drugs versus lifestyle interventions

Andre J. Scheen

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)

添加到收藏夹

Article Endocrinology & Metabolism

Dietary adherence and weight loss success among overweight women: results from the A TO Z weight loss study

S. Alhassan et al.

INTERNATIONAL JOURNAL OF OBESITY (2008)

添加到收藏夹

Article Medicine, General & Internal

Comparison of the Atkins, Ornish, Weight watchers, and Zone diets for weight loss and heart disease risk reduction

ML Dansinger et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

添加到收藏夹

Article Cell Biology

Influence of short-term repeated fasting on the longevity of female (NZB x NZW)F1 mice

H Sogawa et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.